NR3C1 and depressive symptom measurement: Since the chronic stressors in the CPSU and CSD animal models could be understood as the integration of different acute stressors, mifepristone blocks the glucocorticoid receptor and invalidates the end-product of the HPA axis, and eventually exerts a positive effect on reducing depression-like behavior and protecting the gastric mucosa.